Case Study: Arcus Biosciences achieves faster, more efficient research with Seqera

Seqera Labs helps Arcus Biosciences improve research productivity and position itself for future growth

Arcus Biosciences, a clinical-stage biopharmaceutical company focused on oncology, needed a better way to support both research and clinical trial workflows. Its previous pipeline tools were difficult for researchers to use, lacked strong monitoring and traceability, and contributed to inefficiencies, overspending, and bottlenecks for teams with limited Linux expertise. Seqera helped address these challenges with Nextflow and the Seqera platform.

Seqera implemented Nextflow with the Seqera platform across AWS and on-premises HPC infrastructure, enabling self-service access, better collaboration, and secure workspace-based organization for different teams and trials. The result was dramatic productivity gains, with about 95% of workloads managed by Nextflow, plus a 40-50% reduction in cloud spending and a more flexible foundation for future growth.

Arcus Biosciences

Michael Farias

Director of IT